Researchers developed an RNA-based injection that prompts muscle cells to produce a natural heart-protective hormone for ...
Early GO decision reached ahead of Q2'26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants completing open-label Part A Key objectives achieved: ...